Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Framework vs Novi

Framework
Graded #485

Lower grade

vs+8.299999999999997
Novi
Graded #331

Higher grade

The verdict

Novi takes it — 59.9/100 to 51.6/100.

Novi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Novi Health International is a Delaware-based telehealth provider offering compounded semaglutide and tirzepatide with all-in transparent pricing — medication, unlimited clinician support, and free 2-day…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNovi +7
45
52
Dose & formulationNovi +24
40
64
Clinical oversightNovi +5
72
77
Labs & monitoringNovi +3
52
55
FulfillmentNovi +17
57
74
Contract termsFramework +21
41
20
Framework · left barNovi · right bar

The numbers

MetricFrameworkNovi
WeighScore51.6/10059.9/100
GradeCC
Scorecard rank#485#331
SemaglutideNot disclosed$174/mo (starting dose, compounded)
TirzepatideNot disclosed$283/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Framework

Graded #485 · C

Strengths

  • The compounding pharmacy partner is named, which most of this field does not do
  • Treatment selection is doctor-guided rather than a fixed product menu
  • US-licensed clinicians and a 503A pharmacy pathway

Where it loses points

  • No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
  • The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
  • A '$75/month with 3-month package' figure is footnoted as a promotion for new GLP-1 users only
  • Different landing pages advertise different per-week rates, $25 on one and $19 on another
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Novi

Graded #331 · C

Strengths

  • Transparent all-in monthly pricing — medication, clinician support, and shipping bundled with no hidden fees or membership add-ons
  • Both compounded semaglutide and tirzepatide available
  • Unlimited clinician messaging included at no extra cost
  • Free 2-day shipping on every refill

Where it loses points

  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
  • 3-month minimum commitment is non-refundable per Terms of Service unless a clinician deems treatment medically inappropriate
  • State availability and pharmacy partners not publicly listed — patients learn during intake which states and pharmacies serve them

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard